世界卫生组织头颈部肿瘤分类第 5 版更新：口咽和鼻咽。
Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Oropharynx and Nasopharynx.
机构信息
Service d'Anatomo-Pathologie, Department of Pathology, Hôpital Européen G Pompidou, APHP, Université de Paris, 20-40 rue Leblanc, 75015, Paris, France.
出版信息
Head Neck Pathol. 2022 Mar;16(1):19-30. doi: 10.1007/s12105-022-01449-2. Epub 2022 Mar 21.
Abstract
The new WHO classification of head and neck tumors provides a comprehensive overview of lesions by summarizing their clinical, epidemiological, histological, immunohistochemical, molecular and genetic features. The chapters related to the description of oropharyngeal and nasopharyngeal lesions have thus been largely modified.
摘要
世界卫生组织新的头颈部肿瘤分类通过总结其临床、流行病学、组织学、免疫组织化学、分子和遗传学特征，全面概述了病变。因此，与口咽和鼻咽病变描述相关的章节已被大量修改。
相似文献
1
Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Oropharynx and Nasopharynx.
Head Neck Pathol. 2022 Mar;16(1):19-30. doi: 10.1007/s12105-022-01449-2. Epub 2022 Mar 21.
2
Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Oropharynx.
Head Neck Pathol. 2017 Mar;11(1):41-47. doi: 10.1007/s12105-017-0793-2. Epub 2017 Feb 28.
3
Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Hematolymphoid Tumours.
Head Neck Pathol. 2017 Mar;11(1):96-109. doi: 10.1007/s12105-017-0802-5. Epub 2017 Feb 28.
4
Origin of cystic squamous cell carcinoma metastases in head and neck lymph nodes: Addition of EBV testing improves diagnostic accuracy.
Pathol Res Pract. 2016 Jun;212(6):524-31. doi: 10.1016/j.prp.2016.03.002. Epub 2016 Mar 14.
5
Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: What Is New in the 2017 WHO Blue Book for Tumors and Tumor-Like Lesions of the Neck and Lymph Nodes.
Head Neck Pathol. 2017 Mar;11(1):48-54. doi: 10.1007/s12105-017-0796-z. Epub 2017 Feb 28.
6
Update From The 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Nasopharynx.
Head Neck Pathol. 2017 Mar;11(1):16-22. doi: 10.1007/s12105-017-0787-0. Epub 2017 Feb 28.
7
Patterns of EBV-positive cervical lymph node involvement in head and neck cancer and implications for the management of nasopharyngeal carcinoma T0 classification.
Oral Oncol. 2019 Apr;91:7-12. doi: 10.1016/j.oraloncology.2019.01.012. Epub 2019 Feb 16.
8
Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Soft Tissue Tumors.
Head Neck Pathol. 2022 Mar;16(1):87-100. doi: 10.1007/s12105-022-01425-w. Epub 2022 Mar 21.
9
Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Overview of the 2022 WHO Classification of Head and Neck Neuroendocrine Neoplasms.
Head Neck Pathol. 2022 Mar;16(1):123-142. doi: 10.1007/s12105-022-01435-8. Epub 2022 Mar 21.
10
Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Hematolymphoid Proliferations and Neoplasia.
Head Neck Pathol. 2022 Mar;16(1):101-109. doi: 10.1007/s12105-022-01411-2. Epub 2022 Mar 21.
引用本文的文献
1
The treatment outcome of radiation therapy for nasopharyngeal carcinoma in elderly patients: An observational, retrospective, single-center study.
Sci Prog. 2025 Jul-Sep;108(3):368504251374904. doi: 10.1177/00368504251374904. Epub 2025 Sep 1.
2
Integrated Plasma and Tumor Proteomics of Nasopharyngeal Carcinoma in a Moroccan Cohort.
Int J Mol Sci. 2025 Jun 16;26(12):5771. doi: 10.3390/ijms26125771.
3
HPV-Driven Head and Neck Cancer: The European Perspective.
Viruses. 2025 Apr 30;17(5):662. doi: 10.3390/v17050662.
4
Margins in oncologic nasopharyngeal surgery: a systematic review with meta-analysis.
Acta Otorhinolaryngol Ital. 2025 May;45(Suppl. 1):S56-S70. doi: 10.14639/0392-100X-suppl.1-45-2025-N1170.
5
Plasma Epstein-Barr virus DNA for the prediction of treatment response and disease progression in non-keratinizing differentiated nasopharyngeal carcinoma.
Infect Agent Cancer. 2025 May 20;20(1):30. doi: 10.1186/s13027-025-00661-3.
6
Molecular Profiling of Nasopharyngeal Carcinoma Using the AACR Project GENIE Repository.
Cancers (Basel). 2025 May 1;17(9):1544. doi: 10.3390/cancers17091544.
7
A Nomogram Based on Tumor Response to Induction Chemotherapy and Plasma Epstein-Barr Virus DNA Level after Induction Chemotherapy to Explore Individualized Treatment of Patients with Locally Advanced Nasopharyngeal Carcinoma.
J Inflamm Res. 2025 Mar 13;18:3677-3693. doi: 10.2147/JIR.S507926. eCollection 2025.
8
Multi-omics analysis to uncover the molecular basis of tumor budding in head and neck squamous cell carcinoma.
NPJ Precis Oncol. 2025 Mar 13;9(1):73. doi: 10.1038/s41698-025-00856-2.
9
Impact of Epstein-Barr virus and CD lymphocytes on the prognosis of patients with advanced nasopharyngeal carcinoma.
Infect Agent Cancer. 2025 Feb 19;20(1):10. doi: 10.1186/s13027-025-00638-2.
10
Effect of Dendrobium Officinale on Radioactive Oral Mucositis of Nasopharyngeal Carcinoma and Changes of Oral Microecology.
Integr Cancer Ther. 2025 Jan-Dec;24:15347354251313524. doi: 10.1177/15347354251313524.
本文引用的文献
1
Extracapsular extension, pathologic node status, and adjuvant treatment in primary surgery patients with human papillomavirus-mediated oropharyngeal cancer: National hospital-based retrospective cohort analysis.
Head Neck. 2021 Nov;43(11):3345-3363. doi: 10.1002/hed.26825. Epub 2021 Jul 31.
2
All HPV-negative head and neck cancers are not the same: Analysis of the TCGA dataset reveals that anatomical sites have distinct mutation, transcriptome, hypoxia, and tumor microenvironment profiles.
Oral Oncol. 2021 May;116:105260. doi: 10.1016/j.oraloncology.2021.105260. Epub 2021 Mar 13.
3
Low-Grade Nasopharyngeal Papillary Adenocarcinoma: A Review of 28 Patients in a Single Institution.
Cancer Manag Res. 2021 Feb 10;13:1271-1278. doi: 10.2147/CMAR.S288007. eCollection 2021.
4
Timing, number, and type of sexual partners associated with risk of oropharyngeal cancer.
Cancer. 2021 Apr 1;127(7):1029-1038. doi: 10.1002/cncr.33346. Epub 2021 Jan 11.
5
A multivariable Mendelian randomization analysis investigating smoking and alcohol consumption in oral and oropharyngeal cancer.
Nat Commun. 2020 Nov 27;11(1):6071. doi: 10.1038/s41467-020-19822-6.
6
HPV Detection in Head and Neck Squamous Cell Carcinomas: What Is the Issue?
Front Oncol. 2020 Sep 15;10:1751. doi: 10.3389/fonc.2020.01751. eCollection 2020.
7
The Microenvironment of Head and Neck Cancers: Papillomavirus Involvement and Potential Impact of Immunomodulatory Treatments.
Head Neck Pathol. 2020 Jun;14(2):330-340. doi: 10.1007/s12105-020-01147-x. Epub 2020 Mar 2.
8
Distinct biomarker and behavioral profiles of human papillomavirus-related oropharynx cancer patients by age.
Oral Oncol. 2020 Feb;101:104522. doi: 10.1016/j.oraloncology.2019.104522. Epub 2019 Dec 24.
9
NK/T-cell lymphomas.
Best Pract Res Clin Haematol. 2019 Sep;32(3):253-261. doi: 10.1016/j.beha.2019.06.005. Epub 2019 Jun 12.
10
Standard of care vs reduced-dose chemoradiation after induction chemotherapy in HPV+ oropharyngeal carcinoma patients: The Quarterback trial.
Oral Oncol. 2019 Aug;95:170-177. doi: 10.1016/j.oraloncology.2019.06.021. Epub 2019 Jun 25.
Zotero 插件